Related Experiment Videos
Eugenol alleviates dityrosine-triggered insulin resistance and LPS-related inflammatory response by modulating gut
Jia Chen1, Jingnan Zhu1, Qin Jia1
1National Experimental Teaching Demonstration Center for Food Engineering and Quality and Safety, School of Food Science and Biotechnology, Zhejiang Gongshang University, Hangzhou, 310018, China. jxxzgxkwhy@163.com.
Abstract:
Insulin resistance (IR) is a key pathological basis of metabolic diseases. Dityrosine (Dityr), a characteristic protein oxidation product commonly present in over-processed foods, can induce IR by disrupting metabolic homeostasis. Eugenol (EUG), a natural phenolic compound with anti-inflammatory and antioxidant activities, has been shown to improve insulin sensitivity. However, its protective effect and underlying mechanism against Dityr-induced IR remain unclear. The present study aimed to investigate the effect of EUG on Dityr-induced IR in C57BL/6 mice and explore its potential mechanisms. As a result, EUG significantly improved glucose metabolism and lipid metabolism in Dityr-exposed mice in a dose-dependent manner. This study also suggested that EUG effectively decreased the levels of lipopolysaccharide (LPS), LPS-binding protein (LBP), Toll-like receptor 4 (TLR4), nuclear factor kappa B (NFκB), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) and increased the level of interleukin-10 (IL-10) in Dityr-exposed mice. EUG alleviated oxidative stress induced by Dityr and upregulated the expression of the Nrf2/ARE signaling pathway. Importantly, in vivo animal experiments suggested that EUG reshaped the gut microbiota in Dityr-exposed mice at the phylum level, thereby reducing gut microbiota-derived LPS secretion and LPS-related inflammatory response. In conclusion, the effects of EUG on IR and the activation of LPS-related inflammatory response in Dityr-exposed mice might be attributed to the reconstruction of gut microbiota structure.
Related Concept Videos
Dysbiosis of the Gut Microbiota
Microbiota Modulation by Antibiotics
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Gut-Brain Axis